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for cholesterol and phosphatidylserine, 
a homolog of PRTF called SDPR (serum 
deprivation response factor; a phosphati-
dylserine-binding protein) was also identi-
fied in the current screen.
What are the implications of the pres-
ence of PTRF in caveolae? Knockdown 
of PTRF by RNA interference leads to 
a reduction in caveolae density in cul-
tured cells and in zebrafish tissues. Loss 
of morphologically identifiable caveolae 
is accompanied by greater mobility of 
caveolin and its rapid clearance from the 
cell surface by internalization and degra-
dation in lysosomes. Reduced PTRF in 
zebrafish leads to defective tissue archi-
tecture and a shortening and curving of 
the notochord and tail. A similar pheno-
type is also observed when caveolin levels 
are reduced (Nixon et al., 2007). During 
notochord development in the fish, caveo-
lin is expressed earlier than PTRF although 
morphologically distinguishable caveolae 
appear only after PTRF expression. This 
observation suggests a role for caveolin 
outside of caveolae. One possibility is that 
PTRF could modulate the relative amounts 
of caveolae-bound caveolin to free caveo-
lin in the plasma membrane. This ratio is 
likely to influence signaling outcomes from 
caveolin-associated proteins and to mod-
ulate caveolin turnover.
PTRF is a phosphorylated protein 
(Aboulaich et al., 2004), and its associa-
tion with caveolae could be regulated by 
reversible phosphorylation. Pelkmans 
and Zerial (2005) implicated a serine/
threonine kinase ARAF1 in the regula-
tion of caveolae assembly; knockdown of 
ARAF1 by RNA interference dissembles 
caveolae and results in highly mobile 
caveolin. It is tempting to speculate that 
kinases such as ARAF1 could regulate 
the phosphorylation of PTRF and thus 
control caveolae biogenesis. This could 
have consequences for the regulation of 
insulin signaling in adipocytes, as cave-
olae are known to concentrate insulin 
receptors along their margins (Foti et al., 
2007). Moreover, PTRF is a substrate for 
insulin-stimulated phosphorylation, and 
it moves to the cytosol and nucleus after 
insulin treatment.
Characterization of PTRF as a functional 
component of caveolae has broad impli-
cations ranging from caveolae assembly 
to regulation of signaling via caveolin. 
Although the precise function of cave-
olae and a detailed understanding of their 
biogenesis still elude researchers, piecing 
together a molecular jigsaw puzzle regard-
ing the assembly and control of caveolae 
biogenesis is likely to shed new light on 
this fascinating field.
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The long-awaited structure of the effector portion of IRE1, the endoplasmic reticulum stress trans-
ducer, is published in this issue of Cell (Lee et al., 2008). This structure provides new insight into 
the mysterious coupling of kinase and endoribonuclease activities in the oldest, most-conserved 
branch of the unfolded protein response in eukaryotes.Eukaryotic cells respond to the threat of 
protein misfolding in the endoplasmic 
reticulum (ER) by activating an unfolded 24 Cell 132, January 11, 2008 ©2008 Elsevieprotein response (UPR). The UPR reduces 
synthesis of new proteins to relieve the 
load on the stressed ER and upregulates r Inc.genes that promote the ER’s capacity to 
cope with unfolded and misfolded pro-
teins in the long term (Kaufman, 2002; 
Ron and Walter, 2007). Sig-
naling in the UPR is initiated 
by ER-localized transmem-
brane receptors with lume-
nal domains that sense pro-
tein misfolding in the ER (ER 
stress) and cytosolic effector 
domains that pass the sig-
nal on to components further 
downstream.
IRE1, the first such stress 
receptor to be discovered, 
encodes an ER-localized type I 
transmembrane protein with a 
predicted protein serine/threo-
nine kinase domain on its cyto-
plasmic side (Cox et al., 1993; 
Mori et al., 1993). Though an 
otherwise conventional protein 
kinase, the only known phos-
phorylation substrate of IRE1 
is itself. The trans-autophos-
phorylation of IRE1 somehow 
unmasks its effector function, 
which is to cleave a conserved 
mRNA substrate, HAC1, and 
thus promote a splicing event 
that enables HAC1 mRNA to 
be translated into a transcrip-
tion factor. Hac1 then activates UPR target 
genes in yeast (Cox and Walter, 1996), as 
does XBP1, its animal ortholog (Yoshida 
et al., 2001; Calfon et al., 2002). The crys-
tal structure of the cytoplasmic effector 
domain of yeast IRE1, presented in this 
issue by Lee and colleagues (2008), pro-
vides a high-resolution perspective on the 
coupling of IRE1 trans-autophosphoryla-
tion to endoribonucleolytic activity.
In ER-stressed yeast, the HAC1 mRNA 
lacks a 252-nucleotide internal segment 
(intron) whose presence represses Hac1p 
translation. Activated IRE1 cleaves HAC1 
mRNA at two sites to initiate the removal 
of this intron (Sidrauski and Walter, 1997), 
which is followed by ligation of the 5′ and 
3′ HAC1 fragments by yeast tRNA ligase 
(Sidrauski et al., 1996). IRE1-mediated 
cleavage of HAC1 mRNA depends on its 
kinase activity—only wild-type kinase-
active IRE1 is able to cleave its mRNA 
substrate in vitro. ER stress promotes 
IRE1 dimerization, which facilitates 
trans-autophosphorylation and kinase 
activation. However, the basis for the 
coupling of trans-autophosphorylation to 
endoribonucleolytic cleavage at specific 
sequences has remained a mystery.
A serendipitous finding yielded an 
important clue to the mechanism 
involved: In an attempt to selectively 
inhibit IRE1’s kinase activity, leucine 
745 in the putative ATP-binding pocket 
was mutated to a smaller residue (ala-
nine or glycine) to accommodate bind-
ing of a bulky kinase inhibitor (Papa et 
al., 2003). However, instead of thwart-
ing the nuclease activity of IRE1, the 
kinase inhibitor stimulated its activity. 
This remarkable finding indicated that 
the trigger for IRE1’s endoribonuclease 
activity is not phosphorylation per se, 
but rather a conformational change 
in the kinase domain induced by 
nucleotide binding, which is promoted 
by trans-autophosphorylation of the 
kinase activation loop. By binding with 
high affinity in the nucleotide-binding 
cleft of the IRE1 mutant, the inhibitor 
evidently induces the requisite confor-
mational change in the kinase domain 
without need for phosphorylation of 
the activation loop. This result ties in 
with the observation that ADP is more 
effective than ATP in stimulating endor-
ibonuclease activity (Sidrauski and 
Walter, 1997).
This twisted plot provides 
a context for evaluating the 
crystal structure of the effec-
tor cytosolic domain of yeast 
IRE1 (Lee et al., 2008). The 
protein crystallized by Lee 
et al. (2008) has both kinase 
and endoribonuclease activ-
ity and was phosphorylated 
on the activation loop and 
loaded with ADP. Thus, the 
crystal structure likely repre-
sents the active state of the 
enzyme. The structure (Fig-
ure 1) shows a typical bilobed 
protein kinase domain fol-
lowed by the RNase domain, 
dubbed the KEN (kinase-
extension nuclease) domain. 
The KEN domain abuts the 
C-terminal lobe (C-lobe) of 
the kinase domain, shar-
ing an extensive interface. 
This spatial arrangement 
between the relatively rigid 
C-lobe of the kinase domain 
and the nuclease domain is 
likely fixed, irrespective of 
the activation state of IRE1. 
This is an important feature for under-
standing the mechanism linking kinase 
activity to endoribonuclease activity. 
The KEN domain possesses a novel 
fold for a nuclease, comprising eight α 
helices, and thus its catalytic mecha-
nism is undetermined. However, Lee et 
al. (2008) make a strong case that the 
active site is related to that of the endo-
ribonuclease that splices tRNA, despite 
completely different scaffolds.
A critical feature of the crystal struc-
ture is that IRE1 forms a symmetric dimer 
(Figure 1). Dimerization is mediated by 
both kinase-kinase and nuclease-nucle-
ase interactions. In the “back-to-back” 
kinase dimer, both N- and C-lobe resi-
dues contribute to the dimer interface, 
which may explain why nucleotide bind-
ing is required for dimer formation, as it 
stabilizes a closed form of the two lobes. 
The importance of this particular dimeric 
configuration is supported by mutagen-
esis of dimer interface residues, which 
abrogates IRE1’s endonucleolytic activ-
ity (Lee et al., 2008).
Much of the phosphorylated activa-
tion loop is disordered in the crystal 
structure. Although the disposition of 
figure 1. structure of the cytosolic Domain of Yeast IRe1
The two protomers of the IRE1 dimer observed in the crystal structure (two-
fold axis is vertical) are colored purple and green, with the kinase domains in a 
darker shade and the endoribonuclease (KEN) domains in a lighter shade. The 
positions of the kinase and (putative) endoribonuclease active sites are shown 
by arrows, and the bound ADP molecules are colored blue.Cell 132, January 11, 2008 ©2008 Elsevier Inc. 25
the activation loop prior to phospho-
rylation is not known, it is likely that 
the unphosphorylated loop sterically 
restricts nucleotide access to the ATP-
binding cleft, and that trans-autophos-
phorylation induces a rearrangement 
of the loop, granting access to nucle-
otide. (A structure of unphosphorylated 
IRE1 would be revealing in this regard.) 
Indeed, Lee et al. (2008) show that 
ADP binds only to the phosphorylated 
form of IRE1 and induces dimerization 
(albeit weakly). Of course, ATP must 
be capable of binding in the cleft of 
unphosphorylated IRE1 for trans-au-
tophosphorylation to commence. Such 
binding is likely transient, though, and 
only sufficient for trans-autophospho-
rylation upon dimerization of the lume-
nal domains.
With these new structural insights, we 
can now articulate many of the molecu-
lar events in IRE1 activation. ER stress-
induced dimerization of the lumenal 
domain positions the cytosolic domains 
in proximity for trans-autophosphory-
lation of the kinase activation loop. The 
reconfiguration of the activation loop 
upon phosphorylation, together with 
nucleotide binding, promotes forma-
tion of the cytosolic dimer observed in 
the crystal structure. The dimerized KEN 26 Cell 132, January 11, 2008 ©2008 Elseviedomains, stabilized via the dimerized 
kinase domains, are now competent to 
cleave the substrate mRNA.
This study raises interesting ques-
tions for future study: Why does the 
KEN domain need to be a dimer to be 
functional as an endoribonuclease? The 
putative catalytic site appears to be com-
plete in each protomer. It is conceivable 
that dimerization of the KEN domains 
stabilizes the positioning of active-site 
residues. Alternatively, substrate mRNA 
binding may require a composite sur-
face that traverses both protomers. The 
authors also speculate about how an 
IRE1 dimer might coordinately cleave 
the two sites of a single molecule of an 
mRNA substrate. These possibilities, as 
well as the basis for sequence-specific 
mRNA cleavage, might be tested in 
future work through cocrystallization of 
IRE1 and a bound RNA substrate.
How significant in vivo is the observa-
tion that ADP is more effective than ATP 
in stabilizing the active kinase dimer? 
It may be that the millimolar concentra-
tion of ATP in cells and the substantially 
lower concentration of ADP levels the 
playing field. Alternatively, this nucleotide 
preference could be an important aspect 
of the regulatory mechanism—that is, it 
could ensure that IRE1 activation is tran-r Inc.sient and dependent on the ADP off-rate, 
which would keep IRE1 subordinate to 
ER-lumenal stress signals. Although the 
IRE1 story has become decidedly clearer, 
there is undoubtedly more to be learned 
about this remarkable ancient enzyme.
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